Hindustan Bio Sciences Fair Value
Hindustan Bio Sciences (HINDBIO) average fair value is ₹16.06 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹7.16 (+124.3%), fair value range ₹5.0–₹27.12. Browse HINDBIO balance sheet details for revenue, profit, balance sheet and cash flow data.
Fair Value Analysis Export
HINDBIO Fair Value vs Current Price — Valuation Summary
HINDBIO average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. For live price and a broader fundamental view, visit Hindustan Bio Sciences stock price NSE.
P/B Based Valuation
Asset-Based Valuation
HINDBIO Fair Value Analysis — Data Sources & Coverage
Hindustan Bio Sciences financial data sources, valuation methods applied and sector benchmarks used. Read HINDBIO ex-dividend dates for the complete payout history and dividend yield track record.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
HINDBIO vs Information Technology Sector Peers — P/E, P/B & Market Cap
Hindustan Bio Sciences P/E ratio, P/B ratio and market capitalisation vs Information Technology sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Excelsoft Technologies | EXCELSOFT | 19.16 | 1.55 | ₹882 |
| Covance Softsol | COVANCE | 8.06 | 1.94 | ₹325 |
| Xchanging Solutions | XCHANGING | 11.59 | 1.78 | ₹694 |
| Wipro | WIPRO | 12.43 | 1.88 | ₹165,290 |
| Covidh Technologies | COVIDH | 335.29 | 10.6 | ₹89 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.